TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6782486

Group type: EXPERIMENTAL
Intervention: trimethoprim‐sulfamethoxazole plus nystatin
Number of subjects: 53

Group type: COMPARATOR
Intervention: gentamicin plus nystatin
Number of subjects: 53
Study: 29703432

Group type: EXPERIMENTAL
Intervention: Elbasvir 50 mg once daily for 5 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Grazoprevir 100 mg once daily for 7 days
Number of subjects: 0
Study: 27044249

Group type: EXPERIMENTAL
Intervention: Breathlessness Intervention Service (BIS)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 87
Study: 23996473

Group type: EXPERIMENTAL
Intervention: Single intravenous (iv) doses of blosozumab up to 750 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Single subcutaneous (sc) doses of blosozumab 150 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Multiple iv doses of blosozumab up to 750 mg every 2 weeks for 8 weeks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Multiple sc doses of blosozumab up to 270 mg every 2 weeks for 8 weeks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Blosozumab (single or multiple administrations)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 22024822

Group type: EXPERIMENTAL
Intervention: Intravenous doxycycline (40 to 200 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oral doxycycline (40 to 200 mg daily)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Doxycycline (oral administration)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Doxycycline (intravenous and oral)
Number of subjects: 14
Study: 20716558

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) alone
Number of subjects: 418

Group type: COMPARATOR
Intervention: Combination of clomiphene citrate (CC) plus metformin
Number of subjects: 418
Study: 18455526

Group type: EXPERIMENTAL
Intervention: Active management of risk in pregnancy at term (AMOR‐IPAT)
Number of subjects: 270
Study: 16207699

Group type: EXPERIMENTAL
Intervention: Nutrition supplement administered by nursing staff, aiming to meet 45% of estimated energy requirements, starting on day 7 for 42 days
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Nutrition supplement for 'nonrefusers' (n = 35)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Nutrition supplement for 'refusers' (n = 14, 29%)
Number of subjects: 49
Study: 12006122

Group type: EXPERIMENTAL
Intervention: Liposterolic extract of Serenoa repens (LSESr) and beta-sitosterol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 10071274

Group type: EXPERIMENTAL
Intervention: VCP (vincristine, lomustine, and prednisone) after XRT
Number of subjects: 203

Group type: COMPARATOR
Intervention: 8-in-1 chemotherapy before and after XRT
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Children aged 1.5 to younger than 3 years
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Children aged 3 years or older
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: M0 tumors with < or = 1.5 cm2 of residual tumor
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: M0 tumors with > or = 1.5 cm2 of residual tumor
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Tumor spread (MO vs M1 vs M2+) for patients 3 years of age or older
Number of subjects: 203
Study: 7570323

Group type: EXPERIMENTAL
Intervention: OLT candidates after volume infusion (1 L of crystalloid)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Controls (normal liver function)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: PFI (portal flow index) as a predictor
Number of subjects: 25
Study: 2111786

Group type: EXPERIMENTAL
Intervention: Enprostil (70 micrograms)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (vehicle)
Number of subjects: 8
Study: 6794821

Group type: EXPERIMENTAL
Intervention: Hypotonic (0.3%) saline
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Hypertonic (2.7%, 3.6%) saline
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Isotonic (0.9%) saline
Number of subjects: 19

Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 19

Group type: COMPARATOR
Intervention: 3.6% saline
Number of subjects: 19
Study: 31615540

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including provider training (in-person seminar, online course, management algorithms, prescribing feedback) and an information booklet for families
Number of subjects: 410

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 410
Study: 28189180

Group type: EXPERIMENTAL
Intervention: Restrictive RBC transfusion practices
Number of subjects: 0

Group type: COMPARATOR
Intervention: Liberal RBC transfusion practices
Number of subjects: 0
Study: 24531439

Group type: EXPERIMENTAL
Intervention: Peristaltic pulse dynamic compression (PPDC) treatment for 15 minutes on both legs using computer-controlled circumferential inflated leggings.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group with the same procedures as the experimental group but with the inflation pump turned off.
Number of subjects: 24
Study: 23567095

Group type: EXPERIMENTAL
Intervention: Combined treatment
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Hormone therapy
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 450
Study: 21750137

Group type: EXPERIMENTAL
Intervention: High-concentration contrast medium (HCCM) during scheme B (fixed injection flow rate 4 ml s(‐1))
Number of subjects: 30

Group type: COMPARATOR
Intervention: Moderate-concentration contrast medium (MCCM) during scheme B (fixed injection flow rate 4 ml s(‐1))
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-concentration contrast medium (HCCM) during scheme A (fixed injection duration 25 s)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Moderate-concentration contrast medium (MCCM) during scheme A (fixed injection duration 25 s)
Number of subjects: 30
Study: 19800914

Group type: EXPERIMENTAL
Intervention: Hearing conservation program including classroom instruction, distribution of hearing protection devices, direct mailings, noise level assessments, and yearly audiometric testing
Number of subjects: 753

Group type: COMPARATOR
Intervention: Control group received audiometric testing only
Number of subjects: 753
Study: 16965196

Group type: EXPERIMENTAL
Intervention: Long-acting risperidone 25 mg
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Long-acting risperidone 50 mg
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Long-acting risperidone 25 mg and 50 mg
Number of subjects: 324
Study: 12709266

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 10800812

Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional CABG
Number of subjects: 40
Study: 8986186

Group type: EXPERIMENTAL
Intervention: Intra-articular tenoxicam 20 mg in 20 ml of normal saline
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous tenoxicam 20 mg in 2 ml
Number of subjects: 60
Study: 1635724

Group type: EXPERIMENTAL
Intervention: Midwifery management
Number of subjects: 492

Group type: COMPARATOR
Intervention: Physician management
Number of subjects: 492
Study: 6434058

Group type: EXPERIMENTAL
Intervention: Routine care by hospital diabetic clinic
Number of subjects: 200

Group type: COMPARATOR
Intervention: Routine care in general practice
Number of subjects: 200
Study: 31950038

Group type: EXPERIMENTAL
Intervention: Short-segment instrumentation with augmentation by screws and bone substitutes
Number of subjects: 42

Group type: COMPARATOR
Intervention: Long-segment instrumentation without vertebra augmentation
Number of subjects: 42
Study: 27432441

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioural Therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 0
Study: 26516999

Group type: EXPERIMENTAL
Intervention: Popliteal block
Number of subjects: 51

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 51
Study: 23489210

Group type: EXPERIMENTAL
Intervention: 100 mg zanamivir
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 300 mg zanamivir
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 600 mg zanamivir
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 600 mg zanamivir (5-day BID)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 21527004

Group type: EXPERIMENTAL
Intervention: Laser biopsy
Number of subjects: 442

Group type: COMPARATOR
Intervention: Acid Tyrode biopsy
Number of subjects: 442
Study: 19562574

Group type: EXPERIMENTAL
Intervention: 32 g liquorice alone for 2 weeks
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 32 g liquorice combined with 25 mg hydrochlorothiazide for 2 weeks
Number of subjects: 10
Study: 17113896

Group type: EXPERIMENTAL
Intervention: Information about the detection rate
Number of subjects: 137

Group type: COMPARATOR
Intervention: Additional information about the failure to demonstrate the mortality-reducing effect of prostate-specific antigen screening
Number of subjects: 137
Study: 15646908

Group type: EXPERIMENTAL
Intervention: The Wand (computerized anesthesia delivery system)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Traditional syringe (control)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 33
Study: 11531031

Group type: EXPERIMENTAL
Intervention: Pedaling at 41 rpm
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pedaling at 63 rpm
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pedaling at 83 rpm
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Zero-load cycling
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50-watt loaded cycling
Number of subjects: 12
Study: 9434649

Group type: EXPERIMENTAL
Intervention: 17-minute videotape on the consequences of eating a high-fat diet
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo videotape on workplace management
Number of subjects: 192
Study: 7852228

Group type: EXPERIMENTAL
Intervention: Aspirin 325mg (group A, n = 12)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Aspirin 160mg (group B, n = 16)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Aspirin (both doses)
Number of subjects: 28
Study: 2508483

Group type: EXPERIMENTAL
Intervention: Dopamine (DA) infusion at 5 micrograms.kg‐1.min‐1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Dopamine (DA) infusion at 10 micrograms.kg‐1.min‐1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Dopamine (DA) infusion at 2.5 micrograms.kg‐1.min‐1
Number of subjects: 8
Study: 1156147

Group type: EXPERIMENTAL
Intervention: End-to-end (Scott) or end-to-side (Payne) shunts (31 standard length shunts and 21 shortened bypasses)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Shortened bypass procedures
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard bypass procedures
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Overall outcomes of jejunoileal bypass
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: New complications reported
Number of subjects: 52
Study: 31115240

Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy (NA), N=26
Number of subjects: 112

Group type: COMPARATOR
Intervention: Upfront surgery (US), N=86
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Patients who underwent surgery (N=96)
Number of subjects: 112
Study: 30693806

Group type: EXPERIMENTAL
Intervention: True Electroacupuncture (EA)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sham Electroacupuncture (SEA)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control (no acupuncture)
Number of subjects: 51
Study: 28381246

Group type: EXPERIMENTAL
Intervention: FIT programme (daily group handwashing with soap, toothbrushing with fluoride toothpaste, biannual school-based deworming, construction of handwashing facilities)
Number of subjects: 1847

Group type: COMPARATOR
Intervention: Regular government health education curriculum and biannual deworming (Control)
Number of subjects: 1847
Study: 24691156

Group type: EXPERIMENTAL
Intervention: BE-ACTIV
Number of subjects: 82

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 82
Study: 23414978

Group type: EXPERIMENTAL
Intervention: Home-based behavioral intervention for children with persistent asthma
Number of subjects: 300

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 300
Study: 21488935

Group type: EXPERIMENTAL
Intervention: Bone substitute (Algipore(®)) alone
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Bone substitute with resorbable membrane (Osseoquest(®))
Number of subjects: 32

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 32
Study: 18594062

Group type: EXPERIMENTAL
Intervention: Glucagon secretion in response to a mixed meal
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: C-peptide secretion in response to a mixed meal
Number of subjects: 23
Study: 16822105

Group type: EXPERIMENTAL
Intervention: 12-session group cognitive-behavioral therapy (CBT)
Number of subjects: 135

Group type: COMPARATOR
Intervention: group play therapy
Number of subjects: 135

Group type: COMPARATOR
Intervention: general clinic comparison
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: nonsexual offenses (all groups)
Number of subjects: 135
Study: 12921807

Group type: EXPERIMENTAL
Intervention: Metoprolol CR/XL
Number of subjects: 600

Group type: COMPARATOR
Intervention: Gly allele presence
Number of subjects: 600
Study: 10512903

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen treatment (100% oxygen, 3 L/min) for 24 hours
Number of subjects: 292

Group type: COMPARATOR
Intervention: Control group (no additional oxygen)
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen treatment (100% oxygen, 3 L/min) for 24 hours among patients with SSS scores of >/=40
Number of subjects: 292

Group type: COMPARATOR
Intervention: Control group (no additional oxygen) among patients with SSS scores of >/=40
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen treatment (100% oxygen, 3 L/min) for 24 hours among patients with SSS scores of <40
Number of subjects: 292

Group type: COMPARATOR
Intervention: Control group (no additional oxygen) among patients with SSS scores of <40
Number of subjects: 292
Study: 7793298

Group type: EXPERIMENTAL
Intervention: Fasting plasma insulin levels in the FH group
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Fasting plasma insulin levels in obese FH subgroup
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Insulin sensitivity in the FH group
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Insulin sensitivity in obese FH subgroup
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Insulin sensitivity in non-obese FH subgroup
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Correlation between insulin and BMI
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Hormonal parameters including insulin
Number of subjects: 37
Study: 2029134

Group type: EXPERIMENTAL
Intervention: Flucloxacillin alone
Number of subjects: 88

Group type: COMPARATOR
Intervention: Combination of flucloxacillin and metronidazole
Number of subjects: 88

Group type: COMPARATOR
Intervention: Various classic surgical wound types
Number of subjects: 88
Study: 7270617

Group type: EXPERIMENTAL
Intervention: Intrauterine irrigation with cefamandole nafate solution
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intrauterine irrigation with normal saline solution
Number of subjects: 90

Group type: COMPARATOR
Intervention: No irrigation
Number of subjects: 90
Study: 6708603

Group type: EXPERIMENTAL
Intervention: Colestipol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sitosterol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combination of colestipol and sitosterol
Number of subjects: 16
Study: 29659416

Group type: EXPERIMENTAL
Intervention: PICU Soothing intervention (parental comforting with touch and reading, followed by music via soft headbands, administered once daily throughout hospitalization)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 20
Study: 26814276

Group type: EXPERIMENTAL
Intervention: Anodal tDCS targeting the left DLPFC
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cathodal tDCS targeting the left DLPFC
Number of subjects: 40
Study: 24525046

Group type: EXPERIMENTAL
Intervention: l-citrulline malate 1 g three times daily for two weeks
Number of subjects: 25
Study: 22421908

Group type: EXPERIMENTAL
Intervention: Exercise training with curcumin ingestion
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Exercise training with placebo ingestion
Number of subjects: 45

Group type: COMPARATOR
Intervention: Curcumin ingestion
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo ingestion
Number of subjects: 45
Study: 20096030

Group type: EXPERIMENTAL
Intervention: Ampicillin plus gentamicin
Number of subjects: 283

Group type: COMPARATOR
Intervention: Penicillin plus gentamicin
Number of subjects: 283
Study: 17921391

Group type: EXPERIMENTAL
Intervention: Formulas containing graded cystine concentrations (11, 22, 32, 43, or 65 mg cyst(e)ine/100 mL) with generous amounts of methionine.
Number of subjects: 25
Study: 16133496

Group type: EXPERIMENTAL
Intervention: Tunnel restorations
Number of subjects: 182

Group type: COMPARATOR
Intervention: Saucer-shaped restorations
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Both types of restorations
Number of subjects: 182
Study: 12442066

Group type: EXPERIMENTAL
Intervention: 5-day in-patient education programme
Number of subjects: 76
Study: 10629708

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy or hormone therapy with tamoxifen
Number of subjects: 317

Group type: COMPARATOR
Intervention: Organ sparing treatment (sectorial resection +/‐ axillary dissection)
Number of subjects: 317
Study: 7782525

Group type: EXPERIMENTAL
Intervention: Pulsed Nd: YAG laser treatment (113 mJ pulses at 15 pulses s‐1 for 3 min)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 21
Study: 1912540

Group type: EXPERIMENTAL
Intervention: Digital peripheral angiography with stepping and subtraction (DPSA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Digital subtraction angiography without stepping (DSA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional angiography
Number of subjects: 60

Group type: COMPARATOR
Intervention: Digital peripheral angiography without subtraction (DPA)
Number of subjects: 60
Study: 7236868

Group type: EXPERIMENTAL
Intervention: Fencamfamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no acetazolamide)
Number of subjects: 0
Study: 30346026

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (N2 O) inhalation
Number of subjects: 192

Group type: COMPARATOR
Intervention: Local anesthesia (1% lidocaine)
Number of subjects: 192
Study: 30188494

Group type: EXPERIMENTAL
Intervention: Low Exposure (250 μg/m)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High Exposure (500 μg/m)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clean Air (0 μg/m)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Woodsmoke (particulate matter less than 2.5 μm, PM2.5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All trials
Number of subjects: 0
Study: 27980362

Group type: EXPERIMENTAL
Intervention: Toric orthokeratology lenses
Number of subjects: 23
Study: 25315325

Group type: EXPERIMENTAL
Intervention: Antenatal dietary and lifestyle advice
Number of subjects: 2142

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 2142
Study: 22162541

Group type: EXPERIMENTAL
Intervention: MK-5046 (10-160 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20306334

Group type: EXPERIMENTAL
Intervention: Spoon administration of Oral Rehydration Solutions (ORS)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Nasogastric tube administration of Oral Rehydration Solutions (ORS)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Both methods (spoon and nasogastric tube)
Number of subjects: 47
Study: 17608314

Group type: EXPERIMENTAL
Intervention: Low-dose methylphenidate (0.3 mg/kg/dose)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: High-dose methylphenidate (0.5 mg/kg/dose)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 16106488

Group type: EXPERIMENTAL
Intervention: Sodium valproate (1000 mg)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Lithium (900 mg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 12393361

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 30 mg kg(‐1) as a bolus before induction and 10 mg kg(‐1) h(‐1) by continuous i.v. infusion during the operation
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (isotonic solution)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 81
Study: 10355003

Group type: EXPERIMENTAL
Intervention: Immunomodulatory treatment
Number of subjects: 0
Study: 8557002

Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vecuronium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mivacurium
Number of subjects: 0
Study: 1719729

Group type: EXPERIMENTAL
Intervention: Hypervolaemic hemodilution using HES 200/0.5 6%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isovolaemic hemodilution using HES 200/0.5 6%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (infusion of Ringer lactate)
Number of subjects: 0
Study: 6813834

Group type: EXPERIMENTAL
Intervention: Continuous Positive Pressure (CPP)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Intermittent Positive Pressure (IPP)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Classical Respiratory Physiotherapy
Number of subjects: 217
Study: 30535860

Group type: EXPERIMENTAL
Intervention: Wide pitch-window condition (anchor oddball at 850 Hz)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Narrow pitch-window condition (anchor oddball at 550 Hz)
Number of subjects: 0
Study: 30442251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.5 mg kg‐1 S-ketamine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1 mg kg‐1 S-ketamine
Number of subjects: 60